Regarding the PLR-associated genes, PDE4A is a predicted target of miR-4644 and miR-7106-5p, which is suggested to regulate levels of cAMP, an immune suppression agent also involved in tumor pathology [41, 42]. The gene discussed is PDE4A; the disease is neoplasm.